The global diabetic nephropathy market is experiencing significant growth, with revenues reaching around US$ 2.1 billion in 2023 and projected to climb to US$ 3.6 billion by 2032. This growth, marked ...

Breakthroughs in the lab and the tech stack promise a bright future for medicine, leaders agree, but only if equity remains ...

The biggest threat for European pharmaceutical groups currently comes from the United States. President-elect Donald Trump ...

Individuals rely on birth control to treat a host of medical conditions. But birth control has become a hot-button issue, ...

President-elect Donald Trump said Monday that he will issue executive orders imposing new tariffs on all imported goods from ...

Diet is key to preventing, managing, and treating diabetes. This article acts as a diabetes diet guidebook for people with ...

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

Hyderabad: A first-of-its-kind clinical trial in India shows remarkable results for people with diabetes ... the health positively and can supplement medication for diseases like type 2 diabetes.” ...

The findings show that the increased ... Diabetes Medication May Be Effective in Helping People Drink Less Alcohol Nov. 14, 2024 — New research has found that certain types of medication used to ...

The Biden administration's proposed rule could expand coverage of anti-obesity medications for Medicare and Medicaid ...

Clinicians and patients should avoid using compounded GLP-1 products that are not FDA-approved, the American Diabetes Association wrote in a guidance statement published Dec. 2 in Diabetes Care. The ...